Analysis of count data in ms clinical trials

被引：0
|
作者：
Healy, B. [1 ]
机构：
[1] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2020年 / 26卷 / 3_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
LB1194
引用
收藏
页码：73 / 74
页数：2
相关论文
共 50 条
  • [21] MRI monitoring of MS in clinical trials
    Miller, DH
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2002, 104 (03) : 236 - 243
  • [22] Disability as an outcome in MS clinical trials
    Ebers, G. C.
    Heigenhauser, L.
    Daumer, M.
    Lederer, C.
    Noseworthy, J. H.
    NEUROLOGY, 2008, 71 (09) : 624 - 631
  • [23] IMMUNOTHERAPY FOR MS - CLINICAL ASPECTS AND TRIALS
    EBERS, GC
    SIBLEY, WA
    PATY, DW
    ACTA NEUROLOGICA SCANDINAVICA, 1995, 91 : 54 - 54
  • [24] SURROGATE MARKERS IN MS CLINICAL TRIALS
    Sormani, Maria Pia
    BONE MARROW TRANSPLANTATION, 2010, 45 : S15 - S15
  • [25] Ethical issues in MS clinical trials
    Miller, A
    MULTIPLE SCLEROSIS, 2005, 11 (01): : 97 - 98
  • [26] Contrasting Bayesian analysis of survey data and clinical trials
    Malec, DJ
    STATISTICS IN MEDICINE, 2001, 20 (9-10) : 1363 - 1371
  • [27] Analysis of Drug Safety Data From Clinical Trials
    Andrzej Czarnecki
    Katarzyna Zalewska
    Drug information journal : DIJ / Drug Information Association, 2002, 36 (1): : 157 - 162
  • [28] Longitudinal data analysis (repeated measures) in clinical trials
    Albert, PS
    STATISTICS IN MEDICINE, 1999, 18 (13) : 1707 - 1732
  • [29] Analysis of drug safety data from clinical trials
    Czarnecki, A
    Zalewska, K
    DRUG INFORMATION JOURNAL, 2002, 36 (01): : 157 - 162
  • [30] Analysis of data dictionary formats of HIV clinical trials
    Mayer, Craig S.
    Williams, Nick
    Huser, Vojtech
    PLOS ONE, 2020, 15 (10):
12345